Yes. Ask the company sponsoring it (or if possible doctors participating in trials), and read the press releases. Sometimes the information is buried deep in company financial statements & quarterly reports.
Originally Posted by ringo
If a drug dies in Phase III, there is always news about it at some stage because investors have a right to know. But there can be long gaps. Judging purely by time elapsed since last news, you might assume Rebamipide was a goner but it's not. I think the first Phase IIIs were messed up and they had to start over with a new partner last year.
If it dies in Phase II, there may or may not be a press release or it may be mentioned in financial reports. In those situations it's either safety or efficacy or both - but bear in mind efficacy can mean any number of things. It may work on a lot of people but not predictably enough, or it may work on too small a sub-population of dry eye to be economically viable. Sometimes there is just no more news and in that case the implication is pretty obvious. Personally I don't consider myself smart enough to double-guess the scientists' evaluation of the results... and much as I may succumb to the temptation to frequently gripe about pharmaceuticals still I know they are very highly motivated to get another dry eye drug on the market.
So in brief, either hunt for the news (it IS there) or subscribe to my newsletter
This thread was started by mylittlem specifically about the current hormone-based treatments. If anyone has further information please let us know.
The Dry Eye Zone